SNWV

SANUWAVE Health, Inc. Common Stock

37.00 USD
+0.02
0.05%
At close Updated Sep 15, 10:16 AM EDT
1 day
0.05%
5 days
2.72%
1 month
-4.17%
3 months
19.55%
6 months
16.54%
Year to date
27.59%
1 year
27.59%
5 years
27.59%
10 years
27.59%
 

About: SANUWAVE Health Inc is an ultrasound and shock wave technology company using patented systems of noninvasive, high-energy, acoustic shock waves or low-intensity and non-contact ultrasound for regenerative medicine and other applications. The company's focus is regenerative medicine utilizing noninvasive, acoustic shock waves or ultrasound to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's two primary systems are UltraMIST and PACE. UltraMIST and PACE are the only two Food and Drug Administration (FDA) approved directed energy systems for wound healing.

Employees: 46

0
Funds holding %
of 7,463 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

386% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 7

142% more funds holding

Funds holding: 19 [Q1] → 46 (+27) [Q2]

20% more capital invested

Capital invested by funds: $88.5M [Q1] → $106M (+$17.8M) [Q2]

8.44% more ownership

Funds ownership: 29.26% [Q1] → 37.7% (+8.44%) [Q2]

33% less funds holding in top 10

Funds holding in top 10: 3 [Q1] → 2 (-1) [Q2]

50% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 6

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$55
49% upside
Avg. target
$55
49% upside
High target
$55
49% upside

2 analyst ratings

positive
100%
neutral
0%
negative
0%
Northland Capital Markets
Carl Byrnes
$55
Outperform
Initiated
3 Sep 2025
Roth Capital
Kyle Bauser
$55
Buy
Maintained
22 Aug 2025

Financial journalist opinion

Neutral
Seeking Alpha
1 month ago
SANUWAVE Health, Inc. (SNWV) Q2 2025 Earnings Call Transcript
SANUWAVE Health, Inc. (NASDAQ:SNWV ) Q2 2025 Earnings Conference Call August 8, 2025 8:30 AM ET Company Participants Morgan C. Frank - CEO & Chairman Peter Sorensen - CFO & Secretary Conference Call Participants Albert Hanser - Unidentified Company Christopher Michael Plahm - Tall Pines Capital, LLC Kyle Royal Bauser - ROTH Capital Partners, LLC, Research Division Operator Good day, everyone, and welcome to the SANUWAVE Q2 Earnings Call.
SANUWAVE Health, Inc. (SNWV) Q2 2025 Earnings Call Transcript
Positive
The Motley Fool
1 month ago
Sanuwave (SNWV) Q2 Revenue Jumps 42%
Sanuwave (SNWV) Q2 Revenue Jumps 42%
Sanuwave (SNWV) Q2 Revenue Jumps 42%
Neutral
GlobeNewsWire
1 month ago
Sanuwave Announces Q2 FY2025 Financial Results
Q2 2025 revenues were $10.2 million , up 42% from $7.2 million in Q2 2024. This represents the highest Q2 quarterly revenues in Company history.
Sanuwave Announces Q2 FY2025 Financial Results
Neutral
GlobeNewsWire
1 month ago
Sanuwave Will Host a Conference Call on August 8, 2025 at 8:30 AM (ET) to Present Q2 2025 Financial Results
EDEN PRAIRIE, Minn., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, August 8, 2025, at 8:30 AM (ET) to present its Q2 2025 financial results.
Sanuwave Will Host a Conference Call on August 8, 2025 at 8:30 AM (ET) to Present Q2 2025 Financial Results
Neutral
GlobeNewsWire
1 month ago
Sanuwave Health to Present at Canaccord Genuity Growth Conference
EDEN PRAIRIE, Minn., July 22, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (NASDAQ: SNWV), a leading provider of next-generation, FDA-approved wound care products , today announced, that Morgan Frank, Chief Executive Officer, will present at the 45th Annual Canaccord Genuity Growth Conference, being held August 12–13, 2025, at the InterContinental Hotel in Boston, Massachusetts.
Sanuwave Health to Present at Canaccord Genuity Growth Conference
Positive
Seeking Alpha
3 months ago
Sanuwave: High Growth Wound Care Tech Primed For A Breakout
Sanuwave's UltraMIST offers superior wound care, reducing costs and healing time for hospitals, making it attractive to both providers and insurers. Under new CEO Morgan Frank, Sanuwave has revitalized growth, improved margins, and uplisted to Nasdaq, with the stock price quadrupling since his appointment. Revenue growth is robust, recurring consumables sales strengthen the business model, and the company is on track to triple manufacturing capacity.
Sanuwave: High Growth Wound Care Tech Primed For A Breakout
Neutral
GlobeNewsWire
3 months ago
Sanuwave Health Appoints Industry Veteran Dustin Libby as Executive Vice President of Commercial Operations
EDEN PRAIRIE, Minn., June 03, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ:SNWV), a leading provider of next-generation FDA-approved wound care products, is pleased to announce the hiring of Dustin Libby as its EVP of commercial operations.
Sanuwave Health Appoints Industry Veteran Dustin Libby as Executive Vice President of Commercial Operations
Neutral
GlobeNewsWire
3 months ago
Sanuwave Health Selected for Inclusion in Russell 2000® Index
EDEN PRAIRIE, Minn., May 28, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (NASDAQ: SNWV), a leading provider of next-generation, non-invasive wound care solutions, today announced, as part of the 2025 Russell indexes reconstitution, the Company's inclusion in the Russell 2000® Index.
Sanuwave Health Selected for Inclusion in Russell 2000® Index
Neutral
GlobeNewsWire
3 months ago
Sanuwave Health Appoints Greg Bazar to Board of Directors
EDEN PRAIRIE, Minn., May 28, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (Nasdaq:SNWV), a leading provider of next-generation FDA-approved wound care products, is pleased to announce the addition of Greg Bazar to its Board of Directors.
Sanuwave Health Appoints Greg Bazar to Board of Directors
Neutral
Seeking Alpha
4 months ago
SANUWAVE Health, Inc. (SNWV) Q1 2025 Earnings Call Transcript
SANUWAVE Health, Inc. (NASDAQ:SNWV ) Q1 2025 Earnings Conference Call May 9, 2025 8:30 AM ET Company Participants Morgan Frank - Chairman and CEO Peter Sorensen - CFO Conference Call Participants Carl Byrnes - Northland Capital Markets Albert Hanser - Kestrel Christopher Davis - Founding Asset Management Ian Cassel - IFCM Operator Good day, everyone, and welcome to today's SANUWAVE Earnings Call. At this time, all participants are in a listen-only mode.
SANUWAVE Health, Inc. (SNWV) Q1 2025 Earnings Call Transcript
Charts implemented using Lightweight Charts™